Effect of bisphosphonates combined with calcitriol on bone mineral density of patients with osteoporosis due to endocrine therapy for breast cancer

WANG Yan; SUN Xiaodong; FAN Aling

doi:10.7619/jcmp.20211256

Journal of Clinical Medicine in Practice > 2021 > 25(13): 85-88, 92. > DOI: 10.7619/jcmp.20211256

WANG Yan, SUN Xiaodong, FAN Aling. Effect of bisphosphonates combined with calcitriol on bone mineral density of patients with osteoporosis due to endocrine therapy for breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 85-88, 92. DOI: 10.7619/jcmp.20211256

Citation:

PDF (720 KB)

Effect of bisphosphonates combined with calcitriol on bone mineral density of patients with osteoporosis due to endocrine therapy for breast cancer

Department of Hand Surgery, Tangshan City Second Hospital in Hebei Province, Tangshan, Hebei, 063000

More Information

Received Date: March 23, 2021
Available Online: July 07, 2021
Published Date: July 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To analyze the effect of bisphosphonates combined with calcitriol in the treatment of patients with osteoporosis due to endocrine therapy for breast cancer.
Methods A total of 159 patients with osteoporosis due to endocrine therapy for breast cancer were selected and divided into groups A, B and C, with 53 cases in each group. Group A was treated with calcitriol, group B was treated with calcitriol combined with alendronate sodium (bisphosphonates), and group C was treated with calcitriol combined with ibandronate sodium (bisphosphonates). Bone metabolism indexes, immune cytokines, joint pain, bone mineral density, clinical efficacy and adverse reactions were compared among the three groups.
Results Compared with group A and group B, the tartrate resistant acid phosphatase (TRACP), procollagen of type I N-terminal propeptide (PINP), bone alkaline phosphatase (BALP), bone gla protein (BGP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) and the joint pain score decreased significantly in group C, while the levels of interleukin-10 (IL-10) bone mineral density and TNF-β₁ (TGF-β₁) decreased significantly in group C (P < 0.05). Compared with group A and B, the total effective rate of group C was significantly higher (P < 0.05).
Conclusion Application of bisphosphonates combined with calcitriol can enhance the immune function of patients with osteoporosis due to endocrine therapy for breast cancer, improve the abnormal bone metabolism, and increase the bone mineral density. Among lots of bisphosphonates drugs, the effect of ibandronate sodium is the best.
- bisphosphonates,
- calcitriol,
- breast cancer,
- endocrine therapy,
- osteoporosis

FullText(HTML)

References (19)

References

[1]	THARMAPALAN P, MAHENDRALINGAM M, BERMAN H K, et al. Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention[J]. EMBO J, 2019, 38(14): e100852. http://dialnet.unirioja.es/servlet/articulo?codigo=7014926
[2]	YAO S, LAURENT C A, ROH J M, et al. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study[J]. Breast Cancer Res Treat, 2020, 180(1): 187-195. doi: 10.1007/s10549-019-05518-z
[3]	《中国定量CT(QCT)骨质疏松症诊断指南》工作组, 程晓光, 王亮, 等. 中国定量CT(QCT)骨质疏松症诊断指南(2018)[J]. 中国骨质疏松杂志, 2019, 25(6): 733-737. doi: 10.3969/j.issn.1006-7108.2019.06.001
[4]	LEE Y K, LEE E G, KIM H Y, et al. Osteoporotic fractures of the spine, hip, and other locations after adjuvant endocrine therapy with aromatase inhibitors in breast cancer patients: a meta-analysis[J]. J Korean Med Sci, 2020, 35(46): e403. doi: 10.3346/jkms.2020.35.e403
[5]	CHRISTENSEN C Ø, JENSEN M B, HERMANN A P, et al. Osteoporosis after adjuvant treatment for early-stage breast cancer[J]. Dan Med J, 2020, 67(11): A04200223. http://www.researchgate.net/publication/347935627_Osteoporosis_after_adjuvant_treatment_for_early-stage_breast_cancer
[6]	胡健, 刘晔. 不同剂量骨化三醇联合钙剂对绝经后骨质疏松患者跌倒风险的影响[J]. 临床药物治疗杂志, 2019, 17(4): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYW201904013.htm
[7]	ZHOU W, LIU Y, GUO X, et al. Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis[J]. Osteoporos Int, 2019, 30(8): 1581-1589. doi: 10.1007/s00198-019-05005-7
[8]	顾洁梅, 刘玉娟, 胡云秋, 等. 骨化三醇对绝经后骨量减少或骨质疏松症患者甲状旁腺素和骨转换指标及尿钙变化的影响[J]. 老年医学与保健, 2020, 26(2): 204-207. doi: 10.3969/j.issn.1008-8296.2020.02.010
[9]	杨勉. 阿仑膦酸钠联合运动疗法治疗女性围绝经期骨质疏松临床效果观察[J]. 临床军医杂志, 2020, 48(2): 230, 234. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ202002041.htm
[10]	梁志明, 卢丽清, 邓伟民, 等. 阿仑膦酸钠治疗原发性骨质疏松症的长期疗效及安全性分析[J]. 中国骨质疏松杂志, 2019, 25(7): 975-979. doi: 10.3969/j.issn.1006-7108.2019.07.018
[11]	苟静, 岳建彪, 李霞, 等. 伊班膦酸钠联合唑来膦酸治疗绝经后骨质疏松症患者的临床效果及对生活质量的影响[J]. 疑难病杂志, 2019, 18(4): 383-387. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ201904016.htm
[12]	SONG X, GUO Y Y, ZHAO H. Erythema multiforme caused by ibandronate sodium: a rare case report[J]. Dermatol Ther, 2019, 32(4): e12984. doi: 10.1111/dth.12984
[13]	王巧灵. 补肾壮骨汤联合针灸治疗骨质疏松效果及对骨代谢及骨转换指标的影响[J]. 中华中医药学刊, 2020, 38(9): 78-81. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202009021.htm
[14]	袁家楠, 曹欢, 杨慧慧, 等. 2型糖尿病合并骨质疏松患者血清sFRP5和Apelin-13水平与骨代谢标志物的关系[J]. 中华实用诊断与治疗杂志, 2020, 34(10): 1000-1003. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202010008.htm
[15]	KANIS J A, MCCLOSKEY E V, JOHANSSON H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J]. Osteoporos Int, 2013, 24(1): 23-57.
[16]	WANG Y H, ZHANG W, LIM S M, et al. Interleukin-10-producing B cells help suppress ovariectomy-mediated osteoporosis[J]. Immune Netw, 2020, 20(6): e50. http://www.researchgate.net/publication/348043282_Interleukin-10-Producing_B_Cells_Help_Suppress_Ovariectomy-Mediated_Osteoporosis
[17]	CHEN B, LI H Z. Association of IL-6174G/C (rs1800795) and 572C/G (rs1800796) polymorphisms with risk of osteoporosis: a meta-analysis[J]. BMC Musculoskelet Disord, 2020, 21(1): 1-12. http://www.researchgate.net/publication/341764216_Association_of_IL-6_174GC_rs1800795_and_572CG_rs1800796_polymorphisms_with_risk_of_osteoporosis_a_meta-analysis/download
[18]	YU H, ZHOU W, YAN W, et al. LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-Α[J]. Clin Interv Aging, 2019, 14: 1663-1669. http://www.ncbi.nlm.nih.gov/pubmed/31571846
[19]	GU Z T, XIE D H, HUANG C Q, et al. MicroRNA-497 elevation or LRG1 knockdown promotes osteoblast proliferation and collagen synthesis in osteoporosis via TGF-β₁/Smads signalling pathway[J]. J Cell Mol Med, 2020, 24(21): 12619-12632. doi: 10.1111/jcmm.15826

Cited By

Cited by

Periodical cited type(15)

1.	毛行子，刘奇. 唑来膦酸联合骨化三醇对原发性骨质疏松患者骨密度、骨代谢和IGF-1水平的影响. 吉林医学. 2024(03): 698-700 .
2.	李双进，邢如温，侯勇强，魏彦，田文娟，王薇. 乳腺癌患者血清CEACAM1、SOST、P1NP与骨密度的关系及对骨质疏松症的预测价值. 贵州医科大学学报. 2024(05): 757-762+768 .
3.	张树国，时光，韩立新. 双膦酸盐类药物联合骨化三醇预防老年骨质疏松性胸腰段椎体压缩骨折PVP后再骨折的效果观察. 辽宁医学杂志. 2024(03): 50-54 .
4.	赵翠，朱法豪，李玮. 伊班膦酸钠与唑来膦酸治疗恶性肿瘤骨转移患者的效果对比. 大医生. 2024(10): 17-19 .
5.	毛升，夏志胜. 骨化三醇联合钙剂治疗椎体压缩性骨折伴慢性肾功能不全患者椎体成形术后骨质疏松的疗效. 临床合理用药. 2024(19): 96-99 .
6.	崔宁，曹武杰，王若明. 维生素D联合唑来膦酸对行内分泌治疗的绝经后乳腺癌患者骨代谢的影响. 中国实用医刊. 2024(13): 105-108 .
7.	肖淑芳，蒋先奉. 骨吸收抑制剂治疗骨质疏松的效果评价. 中国实用医药. 2024(22): 115-118 .
8.	张荣华. 骨化三醇联合钙尔奇D治疗社区老年骨质疏松症患者的效果观察. 婚育与健康. 2023(06): 55-57 .
9.	郭吉璇. 双膦酸盐治疗原发性骨质疏松症的应用研究. 智慧健康. 2023(07): 79-82 .
10.	黄健，黄骏，周宗波，陆志夫，王国臣，林月华. 补肾壮督方对中老年骨质疏松性椎体骨折的影响. 世界中医药. 2023(12): 1703-1707 .
11.	王丽梅，刘丽娜，李军. 慢性肾脏疾病患者骨密度异常的研究. 中国骨质疏松杂志. 2023(08): 1245-1248 .
12.	杨盼盼，胡俊，叶小青，谈荣珍，张斌，袁忠. 骨化三醇联合骨疏康胶囊对骨质疏松症患者血清OPG、BGP水平的影响. 检验医学与临床. 2023(22): 3383-3385 .
13.	郭珍珍，程筠，黄文霞. 双膦酸盐类药物对区域骨代谢加速过程中巨噬细胞极化状态的影响. 中国现代药物应用. 2023(21): 173-176 .
14.	王丽蓉. 骨化三醇与阿伦磷酸钠治疗骨质疏松症的临床效果研究. 中国医药指南. 2023(35): 102-105 .
15.	余晓波. 骨质疏松症的临床研究进展. 中国医学创新. 2022(21): 175-178 .

Other cited types(6)

Get Citation

PDF

XML

Article views (387) PDF downloads (25) Cited by(21)

Turn off MathJax

Article Contents

Abstract

References

Effect of bisphosphonates combined with calcitriol on bone mineral density of patients with osteoporosis due to endocrine therapy for breast cancer

Abstract

References

Cited by

Periodical cited type(15)

Other cited types(6)

Catalog

Export File

Citation

Format

Content